It is at the cellular and molecular level, designed for the treatment of well-defined carcinogenic sites, and designing corresponding therapeutic drugs. When drugs enter the body, they will specifically select carcinogenic sites to combine and act, causing tumor cells to die specifically, without Will affect the normal tissue cells around the tumor.
This report aims to provide a comprehensive presentation of the global market for Injectable Targeted Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injectable Targeted Therapy. This report contains market size and forecasts of Injectable Targeted Therapy in global, including the following market information:
Global Injectable Targeted Therapy Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Injectable Targeted Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Monoclonal Antibodies Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Injectable Targeted Therapy include Novartis, Sanofi, GSK, Bayer, Amgen, Merck, AbbiVie, AstraZeneca and Teva, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Injectable Targeted Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Injectable Targeted Therapy Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Injectable Targeted Therapy Market Segment Percentages, by Type, 2022 (%)
Monoclonal Antibodies
Small-Molecules
Immunotoxins
Others
Global Injectable Targeted Therapy Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Injectable Targeted Therapy Market Segment Percentages, by Application, 2022 (%)
Hospitals
Homecare
Specialty Clinics
Others
Global Injectable Targeted Therapy Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Injectable Targeted Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Injectable Targeted Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Injectable Targeted Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Sanofi
GSK
Bayer
Amgen
Merck
AbbiVie
AstraZeneca
Teva
Roche
Pfizer
Outline of Major Chapters:
Chapter 1: Introduces the definition of Injectable Targeted Therapy, market overview.
Chapter 2: Global Injectable Targeted Therapy market size in revenue.
Chapter 3: Detailed analysis of Injectable Targeted Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Injectable Targeted Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Injectable Targeted Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Injectable Targeted Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Injectable Targeted Therapy Overall Market Size
2.1 Global Injectable Targeted Therapy Market Size: 2022 VS 2032
2.2 Global Injectable Targeted Therapy Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Injectable Targeted Therapy Players in Global Market
3.2 Top Global Injectable Targeted Therapy Companies Ranked by Revenue
3.3 Global Injectable Targeted Therapy Revenue by Companies
3.4 Top 3 and Top 5 Injectable Targeted Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Injectable Targeted Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Injectable Targeted Therapy Players in Global Market
3.6.1 List of Global Tier 1 Injectable Targeted Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Injectable Targeted Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Injectable Targeted Therapy Market Size Markets, 2022 & 2032
4.1.2 Monoclonal Antibodies
4.1.3 Small-Molecules
4.1.4 Immunotoxins
4.1.5 Others
4.2 By Type - Global Injectable Targeted Therapy Revenue & Forecasts
4.2.1 By Type - Global Injectable Targeted Therapy Revenue, 2018-2023
4.2.2 By Type - Global Injectable Targeted Therapy Revenue, 2024-2032
4.2.3 By Type - Global Injectable Targeted Therapy Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Injectable Targeted Therapy Market Size, 2022 & 2032
5.1.2 Hospitals
5.1.3 Homecare
5.1.4 Specialty Clinics
5.1.5 Others
5.2 By Application - Global Injectable Targeted Therapy Revenue & Forecasts
5.2.1 By Application - Global Injectable Targeted Therapy Revenue, 2018-2023
5.2.2 By Application - Global Injectable Targeted Therapy Revenue, 2024-2032
5.2.3 By Application - Global Injectable Targeted Therapy Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Injectable Targeted Therapy Market Size, 2022 & 2032
6.2 By Region - Global Injectable Targeted Therapy Revenue & Forecasts
6.2.1 By Region - Global Injectable Targeted Therapy Revenue, 2018-2023
6.2.2 By Region - Global Injectable Targeted Therapy Revenue, 2024-2032
6.2.3 By Region - Global Injectable Targeted Therapy Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Injectable Targeted Therapy Revenue, 2018-2032
6.3.2 US Injectable Targeted Therapy Market Size, 2018-2032
6.3.3 Canada Injectable Targeted Therapy Market Size, 2018-2032
6.3.4 Mexico Injectable Targeted Therapy Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Injectable Targeted Therapy Revenue, 2018-2032
6.4.2 Germany Injectable Targeted Therapy Market Size, 2018-2032
6.4.3 France Injectable Targeted Therapy Market Size, 2018-2032
6.4.4 U.K. Injectable Targeted Therapy Market Size, 2018-2032
6.4.5 Italy Injectable Targeted Therapy Market Size, 2018-2032
6.4.6 Russia Injectable Targeted Therapy Market Size, 2018-2032
6.4.7 Nordic Countries Injectable Targeted Therapy Market Size, 2018-2032
6.4.8 Benelux Injectable Targeted Therapy Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Injectable Targeted Therapy Revenue, 2018-2032
6.5.2 China Injectable Targeted Therapy Market Size, 2018-2032
6.5.3 Japan Injectable Targeted Therapy Market Size, 2018-2032
6.5.4 South Korea Injectable Targeted Therapy Market Size, 2018-2032
6.5.5 Southeast Asia Injectable Targeted Therapy Market Size, 2018-2032
6.5.6 India Injectable Targeted Therapy Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Injectable Targeted Therapy Revenue, 2018-2032
6.6.2 Brazil Injectable Targeted Therapy Market Size, 2018-2032
6.6.3 Argentina Injectable Targeted Therapy Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Injectable Targeted Therapy Revenue, 2018-2032
6.7.2 Turkey Injectable Targeted Therapy Market Size, 2018-2032
6.7.3 Israel Injectable Targeted Therapy Market Size, 2018-2032
6.7.4 Saudi Arabia Injectable Targeted Therapy Market Size, 2018-2032
6.7.5 UAE Injectable Targeted Therapy Market Size, 2018-2032
7 Injectable Targeted Therapy Companies Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Injectable Targeted Therapy Major Product Offerings
7.1.4 Novartis Injectable Targeted Therapy Revenue in Global Market (2018-2023)
7.1.5 Novartis Key News & Latest Developments
7.2 Sanofi
7.2.1 Sanofi Company Summary
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Injectable Targeted Therapy Major Product Offerings
7.2.4 Sanofi Injectable Targeted Therapy Revenue in Global Market (2018-2023)
7.2.5 Sanofi Key News & Latest Developments
7.3 GSK
7.3.1 GSK Company Summary
7.3.2 GSK Business Overview
7.3.3 GSK Injectable Targeted Therapy Major Product Offerings
7.3.4 GSK Injectable Targeted Therapy Revenue in Global Market (2018-2023)
7.3.5 GSK Key News & Latest Developments
7.4 Bayer
7.4.1 Bayer Company Summary
7.4.2 Bayer Business Overview
7.4.3 Bayer Injectable Targeted Therapy Major Product Offerings
7.4.4 Bayer Injectable Targeted Therapy Revenue in Global Market (2018-2023)
7.4.5 Bayer Key News & Latest Developments
7.5 Amgen
7.5.1 Amgen Company Summary
7.5.2 Amgen Business Overview
7.5.3 Amgen Injectable Targeted Therapy Major Product Offerings
7.5.4 Amgen Injectable Targeted Therapy Revenue in Global Market (2018-2023)
7.5.5 Amgen Key News & Latest Developments
7.6 Merck
7.6.1 Merck Company Summary
7.6.2 Merck Business Overview
7.6.3 Merck Injectable Targeted Therapy Major Product Offerings
7.6.4 Merck Injectable Targeted Therapy Revenue in Global Market (2018-2023)
7.6.5 Merck Key News & Latest Developments
7.7 AbbiVie
7.7.1 AbbiVie Company Summary
7.7.2 AbbiVie Business Overview
7.7.3 AbbiVie Injectable Targeted Therapy Major Product Offerings
7.7.4 AbbiVie Injectable Targeted Therapy Revenue in Global Market (2018-2023)
7.7.5 AbbiVie Key News & Latest Developments
7.8 AstraZeneca
7.8.1 AstraZeneca Company Summary
7.8.2 AstraZeneca Business Overview
7.8.3 AstraZeneca Injectable Targeted Therapy Major Product Offerings
7.8.4 AstraZeneca Injectable Targeted Therapy Revenue in Global Market (2018-2023)
7.8.5 AstraZeneca Key News & Latest Developments
7.9 Teva
7.9.1 Teva Company Summary
7.9.2 Teva Business Overview
7.9.3 Teva Injectable Targeted Therapy Major Product Offerings
7.9.4 Teva Injectable Targeted Therapy Revenue in Global Market (2018-2023)
7.9.5 Teva Key News & Latest Developments
7.10 Roche
7.10.1 Roche Company Summary
7.10.2 Roche Business Overview
7.10.3 Roche Injectable Targeted Therapy Major Product Offerings
7.10.4 Roche Injectable Targeted Therapy Revenue in Global Market (2018-2023)
7.10.5 Roche Key News & Latest Developments
7.11 Pfizer
7.11.1 Pfizer Company Summary
7.11.2 Pfizer Business Overview
7.11.3 Pfizer Injectable Targeted Therapy Major Product Offerings
7.11.4 Pfizer Injectable Targeted Therapy Revenue in Global Market (2018-2023)
7.11.5 Pfizer Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Injectable Targeted Therapy Market Opportunities & Trends in Global Market
Table 2. Injectable Targeted Therapy Market Drivers in Global Market
Table 3. Injectable Targeted Therapy Market Restraints in Global Market
Table 4. Key Players of Injectable Targeted Therapy in Global Market
Table 5. Top Injectable Targeted Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Injectable Targeted Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Injectable Targeted Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Injectable Targeted Therapy Product Type
Table 9. List of Global Tier 1 Injectable Targeted Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Injectable Targeted Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Injectable Targeted Therapy Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Injectable Targeted Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Injectable Targeted Therapy Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Injectable Targeted Therapy Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Injectable Targeted Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Injectable Targeted Therapy Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Injectable Targeted Therapy Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Injectable Targeted Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Injectable Targeted Therapy Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Injectable Targeted Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Injectable Targeted Therapy Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Injectable Targeted Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Injectable Targeted Therapy Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Injectable Targeted Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Injectable Targeted Therapy Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Injectable Targeted Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Injectable Targeted Therapy Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Injectable Targeted Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Injectable Targeted Therapy Revenue, (US$, Mn), 2024-2032
Table 30. Novartis Company Summary
Table 31. Novartis Injectable Targeted Therapy Product Offerings
Table 32. Novartis Injectable Targeted Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. Novartis Key News & Latest Developments
Table 34. Sanofi Company Summary
Table 35. Sanofi Injectable Targeted Therapy Product Offerings
Table 36. Sanofi Injectable Targeted Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Sanofi Key News & Latest Developments
Table 38. GSK Company Summary
Table 39. GSK Injectable Targeted Therapy Product Offerings
Table 40. GSK Injectable Targeted Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. GSK Key News & Latest Developments
Table 42. Bayer Company Summary
Table 43. Bayer Injectable Targeted Therapy Product Offerings
Table 44. Bayer Injectable Targeted Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. Bayer Key News & Latest Developments
Table 46. Amgen Company Summary
Table 47. Amgen Injectable Targeted Therapy Product Offerings
Table 48. Amgen Injectable Targeted Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. Amgen Key News & Latest Developments
Table 50. Merck Company Summary
Table 51. Merck Injectable Targeted Therapy Product Offerings
Table 52. Merck Injectable Targeted Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. Merck Key News & Latest Developments
Table 54. AbbiVie Company Summary
Table 55. AbbiVie Injectable Targeted Therapy Product Offerings
Table 56. AbbiVie Injectable Targeted Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. AbbiVie Key News & Latest Developments
Table 58. AstraZeneca Company Summary
Table 59. AstraZeneca Injectable Targeted Therapy Product Offerings
Table 60. AstraZeneca Injectable Targeted Therapy Revenue (US$, Mn) & (2018-2023)
Table 61. AstraZeneca Key News & Latest Developments
Table 62. Teva Company Summary
Table 63. Teva Injectable Targeted Therapy Product Offerings
Table 64. Teva Injectable Targeted Therapy Revenue (US$, Mn) & (2018-2023)
Table 65. Teva Key News & Latest Developments
Table 66. Roche Company Summary
Table 67. Roche Injectable Targeted Therapy Product Offerings
Table 68. Roche Injectable Targeted Therapy Revenue (US$, Mn) & (2018-2023)
Table 69. Roche Key News & Latest Developments
Table 70. Pfizer Company Summary
Table 71. Pfizer Injectable Targeted Therapy Product Offerings
Table 72. Pfizer Injectable Targeted Therapy Revenue (US$, Mn) & (2018-2023)
Table 73. Pfizer Key News & Latest Developments
List of Figures
Figure 1. Injectable Targeted Therapy Segment by Type in 2022
Figure 2. Injectable Targeted Therapy Segment by Application in 2022
Figure 3. Global Injectable Targeted Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Injectable Targeted Therapy Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Injectable Targeted Therapy Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Injectable Targeted Therapy Revenue in 2022
Figure 8. By Type - Global Injectable Targeted Therapy Revenue Market Share, 2018-2032
Figure 9. By Application - Global Injectable Targeted Therapy Revenue Market Share, 2018-2032
Figure 10. By Type - Global Injectable Targeted Therapy Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Injectable Targeted Therapy Revenue Market Share, 2018-2032
Figure 12. By Application - Global Injectable Targeted Therapy Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Injectable Targeted Therapy Revenue Market Share, 2018-2032
Figure 14. By Region - Global Injectable Targeted Therapy Revenue Market Share, 2018-2032
Figure 15. By Country - North America Injectable Targeted Therapy Revenue Market Share, 2018-2032
Figure 16. US Injectable Targeted Therapy Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Injectable Targeted Therapy Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Injectable Targeted Therapy Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Injectable Targeted Therapy Revenue Market Share, 2018-2032
Figure 20. Germany Injectable Targeted Therapy Revenue, (US$, Mn), 2018-2032
Figure 21. France Injectable Targeted Therapy Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Injectable Targeted Therapy Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Injectable Targeted Therapy Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Injectable Targeted Therapy Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Injectable Targeted Therapy Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Injectable Targeted Therapy Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Injectable Targeted Therapy Revenue Market Share, 2018-2032
Figure 28. China Injectable Targeted Therapy Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Injectable Targeted Therapy Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Injectable Targeted Therapy Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Injectable Targeted Therapy Revenue, (US$, Mn), 2018-2032
Figure 32. India Injectable Targeted Therapy Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Injectable Targeted Therapy Revenue Market Share, 2018-2032
Figure 34. Brazil Injectable Targeted Therapy Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Injectable Targeted Therapy Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Injectable Targeted Therapy Revenue Market Share, 2018-2032
Figure 37. Turkey Injectable Targeted Therapy Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Injectable Targeted Therapy Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Injectable Targeted Therapy Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Injectable Targeted Therapy Revenue, (US$, Mn), 2018-2032
Figure 41. Novartis Injectable Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Sanofi Injectable Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. GSK Injectable Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Bayer Injectable Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Amgen Injectable Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Merck Injectable Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. AbbiVie Injectable Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. AstraZeneca Injectable Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Teva Injectable Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Roche Injectable Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Pfizer Injectable Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
